DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

Novo Nordisk (NYSE: NVO)

company name or ticker
Company Photos
(Click to zoom)

The Weekender

Trophy Growth Stocks

The Best Company for Investing in the Diabetes Market

Diabetes spending is growing rapidly, and this company is the best way for investors to capitalize on the trend.

Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q1 2015 Results - Earnings Call Transcript

Novo Nordisk (NVO) Beats on Q1 Earnings, Updates Outlook - Analyst Blog

Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE

Novo Nordisk CFO: U.S. Obesity Market Must Emerge, But It Will Take Time

Novo Nordisk Posts Rise In Profit

MannKind Looks Good For Long Term Investors

MannKind's Future: More than Just Afrezza?

MannKind's pipeline of opportunity is explored.
See More Articles...